135 related articles for article (PubMed ID: 11318417)
21. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans.
Jacqz-Aigrain E; Funck-Brentano C; Cresteil T
Pharmacogenetics; 1993 Aug; 3(4):197-204. PubMed ID: 8220439
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of dextromethorphan N-demethylation activity as a biomarker for cytochrome P450 3A activity in man.
Kawashima Y; Hagiwara M; Inoue Y; Someya T
Pharmacol Toxicol; 2002 Feb; 90(2):82-8. PubMed ID: 12071430
[TBL] [Abstract][Full Text] [Related]
23. UPLC-MS/MS analysis of dextromethorphan-O-demethylation kinetics in rat brain microsomes.
DuBois BN; Mehvar R
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1096():66-72. PubMed ID: 30149296
[TBL] [Abstract][Full Text] [Related]
24. Automated determination of dextromethorphan and its main metabolites in human plasma by high-performance liquid chromatography and column switching.
Härtter S; Baier D; Dingemanse J; Ziegler G; Hiemke C
Ther Drug Monit; 1996 Jun; 18(3):297-303. PubMed ID: 8738772
[TBL] [Abstract][Full Text] [Related]
25. Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity.
Kashuba AD; Nafziger AN; Kearns GL; Leeder JS; Gotschall R; Gaedigk A; Bertino JS
Pharmacogenetics; 1999 Aug; 9(4):453-62. PubMed ID: 10780265
[TBL] [Abstract][Full Text] [Related]
26. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
Witherow LE; Houston JB
J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
[TBL] [Abstract][Full Text] [Related]
27. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
Zhang S; Song N; Li Q; Fan H; Liu C
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
[TBL] [Abstract][Full Text] [Related]
28. Determination of dextromethorphan and its O-demethylated metabolite from urine.
Marshall PS; Straka RJ; Johnson K
Ther Drug Monit; 1992 Oct; 14(5):402-7. PubMed ID: 1448849
[TBL] [Abstract][Full Text] [Related]
29. Quantitative determination of dextromethorphan and three metabolites in urine by reverse-phase high-performance liquid chromatography.
Park YH; Kullberg MP; Hinsvark ON
J Pharm Sci; 1984 Jan; 73(1):24-9. PubMed ID: 6694076
[TBL] [Abstract][Full Text] [Related]
30. Intra-individual variability and influence of urine collection period on dextromethorphan metabolic ratios in healthy subjects.
Chládek J; Zimová G; Martínková J; Tůma I
Fundam Clin Pharmacol; 1999; 13(4):508-15. PubMed ID: 10456294
[TBL] [Abstract][Full Text] [Related]
31. The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.
Kerry NL; Somogyi AA; Bochner F; Mikus G
Br J Clin Pharmacol; 1994 Sep; 38(3):243-8. PubMed ID: 7826826
[TBL] [Abstract][Full Text] [Related]
32. Determination of dextromethorphan and its metabolite dextrorphan in human urine using high performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry: a study of selectivity of a tandem mass spectrometric assay.
Constanzer ML; Chavez-Eng CM; Fu I; Woolf EJ; Matuszewski BK
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):297-308. PubMed ID: 15664362
[TBL] [Abstract][Full Text] [Related]
33. Development of a rapid and sensitive high-performance liquid chromatographic method to determine CYP2D6 phenotype in human liver microsomes.
Rege B; March C; Sarkar MA
Biomed Chromatogr; 2002 Feb; 16(1):31-40. PubMed ID: 11816009
[TBL] [Abstract][Full Text] [Related]
34. [Column switching HPLC method for determination of dextrorphan, an active metabolite of dextromethorphan, in plasma].
Liu LL; Wang Z; Feng XT; Gao S
Yao Xue Xue Bao; 1993; 28(5):374-8. PubMed ID: 8237384
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of dextromethorphan in human liver microsomes: a rapid HPCL assay to monitor cytochrome P450 2D6 activity.
Vielnascher E; Spatzenegger M; Mayrhofer A; Klinger P; Jäger W
Pharmazie; 1996 Aug; 51(8):586-8. PubMed ID: 8794469
[TBL] [Abstract][Full Text] [Related]
36. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
Gorski JC; Jones DR; Wrighton SA; Hall SD
Biochem Pharmacol; 1994 Jul; 48(1):173-82. PubMed ID: 8043020
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous determination of dextromethorphan and its metabolites in human plasma by capillary electrophoresis.
Kristensen HT
J Pharm Biomed Anal; 1998 Dec; 18(4-5):827-38. PubMed ID: 9919985
[TBL] [Abstract][Full Text] [Related]
38. High performance liquid chromatography determination of dextromethorphan and its metabolites in urine using solid-phase extraction.
Bartoletti RA; Belpaire FM; Rosseel MT
J Pharm Biomed Anal; 1996 Jun; 14(8-10):1281-86. PubMed ID: 8818046
[TBL] [Abstract][Full Text] [Related]
39. High performance liquid chromatographic determination of dextromethorphan and its metabolite in human urine.
Cai WM; Chen B; Chu X
Yao Xue Xue Bao; 1997 Nov; 32(11):861-4. PubMed ID: 11596206
[TBL] [Abstract][Full Text] [Related]
40. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan.
Tyndale RF; Li Y; Li NY; Messina E; Miksys S; Sellers EM
Drug Metab Dispos; 1999 Aug; 27(8):924-30. PubMed ID: 10421620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
